ConnectomeDiffuser: Generative AI Enables Brain Network Construction from Diffusion Tensor Imaging

TL;DR

ConnectomeDiffuser introduces a novel AI-driven framework that automates the construction of brain networks from DTI scans, capturing complex topological features and disease markers to improve neurodegenerative disorder analysis.

Contribution

It presents an end-to-end diffusion-based model combining topological feature extraction, generative network modeling, and disease classification, advancing neuroimaging instrumentation.

Findings

Outperforms existing methods in capturing structural connectivity.

Enhances sensitivity to individual brain network variations.

Demonstrates significant accuracy improvements in neurodegenerative disease datasets.

Abstract

Brain network analysis plays a crucial role in diagnosing and monitoring neurodegenerative disorders such as Alzheimer's disease (AD). Existing approaches for constructing structural brain networks from diffusion tensor imaging (DTI) often rely on specialized toolkits that suffer from inherent limitations: operator subjectivity, labor-intensive workflows, and restricted capacity to capture complex topological features and disease-specific biomarkers. To overcome these challenges and advance computational neuroimaging instrumentation, ConnectomeDiffuser is proposed as a novel diffusion-based framework for automated end-to-end brain network construction from DTI. The proposed model combines three key components: (1) a Template Network that extracts topological features from 3D DTI scans using Riemannian geometric principles, (2) a diffusion model that generates comprehensive brain networks with enhanced topological fidelity, and (3) a Graph Convolutional Network classifier that incorporates disease-specific markers to improve diagnostic accuracy. ConnectomeDiffuser demonstrates superior performance by capturing a broader range of structural connectivity and pathology-related information, enabling more sensitive analysis of individual variations in brain networks. Experimental validation on datasets representing two distinct neurodegenerative conditions demonstrates significant performance improvements over other brain network methods. This work contributes to the advancement of instrumentation in the context of neurological disorders, providing clinicians and researchers with a robust, generalizable measurement framework that facilitates more accurate diagnosis, deeper mechanistic understanding, and improved therapeutic monitoring of neurodegenerative diseases such as AD.